I-iiMedia Ranking · 2025 China Innovative Drugs Global Expansion Leadership Ranking yethulwe ngokukhulu ukuduma eSingapore. Njengomshicileli kanye nomlingani wezinhlelo, iStellar Biotech yasebenzisa inethiwekhi yayo yezinsizakalo ezisezingeni eliphezulu ezisetshenziswa kakhulu eNingizimu-mpumalanga Asia ukusiza izinkampani ezithuthukisa imithi ezintsha ezivela eChina ukuthi zizakhele isikhundla esiqinile eSingapore futhi zakhe isikhungo sezokwelapha esifundeni. Lolu hlu luhlanganisa "iqembu likazwelonke" lemithi emisha yaseChina okubalwa kuyo i-3SBio, i-Innovent Biologics, neSinopharm Group, lugqamisa inani le-Singapore elibalulekile njengendlela "yokuqala" yemithi emisha yaseChina eya emhlabeni wonke futhi luvula isahluko esisha ekubambisaneni kwezimboni zemithi phakathi kweChina neSingapore.

Isikhundla sokuqala sobungcweti emhlabeni esigxile ekwandisweni komhlaba wonke kwemithi emisha — iiMedia Ranking · 2025 China Innovative Drugs Global Expansion Leadership Ranking — sikhishwe ngokusemthethweni eSingapore ngoNovemba 17, 2025. Njengohlelo lokuhlola olunamandla ngaphansi kwe-iiMedia Research, lesi sikhundla sisekelwa uhlelo oluzenzakalelayo lwe-CMDAS olusekelwe kudatha enkulu futhi lunemodeli yokuqala yokuhlola enezinhlangothi ezine: Izithiyo Zobuchwepheshe + Inqubekela Phambili Yomhlaba Wonke + Amandla Okuthengisa + Amandla Okusebenza Esifundeni. Kusuka ezinkampanini zemithi zaseShayina ezicishe zibe yi-4,000, kukhethwe ngokunembayo Izinkampani Eziyi-Top 40 Eziholela phambili, okubandakanya: WuXi AppTec, BeiGene, CSPC Pharmaceutical, Sinopharm Group, Kelun Pharmaceutical, Shanghai Pharmaceuticals, Baili Tianheng, 3SBio, Ascentage Pharma, United Laboratories, Hengrui Medicine, Fosun Pharma, Huadong Medicine, Sinovac Biotech, Legend Biotech, Hansoh Pharma, Healthcare, Yifan Pharmaceutical, Innovent Biologics, Akeso Biologics, Junshi Biosciences, Zai Lab, Gan & Lee Pharmaceuticals, Rongchang Biologics, GenSci, Porton Pharma, YingEn Biologics, Everest Medicines, Hutchison MediPharma, Simcere Pharmaceutical, Deqiao Therapeutics, Aosaikang, Lepu Biologics, Jacobi Therapeutics, I-Mab, Dizal Pharma, 3D Medicines, Harbour BioMed, Lavel Biotech, PuraPharm Biologics.

Kusukela ngoNovemba 18, 2025, inani eliphelele lokuthengiselana ngamalayisense emithi yaseShayina eyiNoveli lidlule ku-USD 103.43 billion, okumele ukwanda okungu-90.51% unyaka nonyaka kusuka ku-USD 54.29 billion esikhathini esigcwele sika-2024. Cishe u-80% wale mali ethengiwe ivela ezinkampanini ezisesikhundleni.

Ukuqala kwe-iiMedia Ranking eSingapore kugcizelela indima yalo njengeziko eliyinhloko lemithi eNingizimu-mpumalanga ye-Asia, elinomthelela omkhulu wezamasu. Le nkundla ibeka iSingapore njengesikhungo samasu esixhumanisa imithi yaseShayina enobuchule nezimakethe zomhlaba wonke, iqinisa umthelela we-Asia-Pacific endaweni yobuchule bemithi emhlabeni wonke, ihambisa izinsiza ezisezingeni eliphezulu zaseShayina ezimbonini zemithi ye-biopharmaceutical yaseSingapore, futhi ikhuthaza ukuhamba kobuchwepheshe nemali phakathi kwezinhlangothi zombili. Ngaleso sikhathi, ngokusebenzisa iSingapore njengendawo "yokuqalisa", izinkampani zemithi yaseShayina ezinobuchule zingandisa ngokushesha emazweni ayi-10 aseNingizimu-mpumalanga ye-Asia, i-Australia kanye neNew Zealand, zakha uhlelo olugcwele lwe-R&D — Ukubhaliswa — Ukuthengiswa.

Njengomlingani wezinguquko ezikhethekile zokubalwa, i-Stellar Biotech ihlinzeka ngezinsizakalo eziyisinyathelo esisodwa kusukela ekubhalisweni kwezimiso kuya ekuthengisweni kwezinkampani ezifakwe ohlwini, kusekelwa inethiwekhi yayo enamandla "yezindawo ezimbili ezinkulu + ukumbozwa kwesifunda sonke" kanye nolwazi olubanzi lokubhalisa kwamanye amazwe. Izinsizakalo zayo eziyinhloko zihlanganisa izixhumanisi ezibalulekile ezifaka izicelo zokubhalisa zesifunda, ukwakhiwa kwenethiwekhi yokusabalalisa yendawo, kanye nokusekelwa kwezinto zokuthutha ezibandayo ezingaphezu kwemingcele, kuxazulula ngempumelelo izinselele zendawo ezinkampanini zemithi yaseShayina ezihamba emhlabeni jikelele.

Leli modeli lokunika amandla liletha inani elibonakalayo eSingapore: Ukungena kwezinkampani ezintsha zemithi ezivela eShayina kukhuthaza ukukhula kwamabhizinisi ahlobene nemithi futhi kudala imisebenzi edinga amakhono aphezulu; ukuqaliswa kwephrojekthi nokusebenza emakethe kunomthelela ngqo kuhulumeni wentela, kugcwalisa umdlandla omusha emnothweni waseSingapore. Okubaluleke kakhulu, njengomkhuba omusha we-"professional ranking + market empowerment" model, iStellar Biotech, njengomqhubi oyinhloko, iguqula "inani lokuhlola" lokuhlelwa libe "inani lokuqaliswa". Ngokuhlanganyela ukuhlela ama-salons ahambisana neNingizimu-mpumalanga ye-Asia, imihlangano yokufanisa uhulumeni nezinkampani, kanye nezingqungquthela zokufanisa izinsiza zezokwelapha, iStellar Biotech isiza izinkampani ezisohlwini ukuthi ziqonde ngokushesha imithetho yezimakethe zesifunda. Le modeli yokubambisana yandisa umthelela womkhakha wokuhlelwa ngeziyalo zeStellar Biotech ezisekelwe emhlabeni, iphinde yenyuse isithunzi saseSingapore njengesikhungo sezinsizakalo zemithi.

UMnu. Lin, Usihlalo we-Stellar Biotech, uthe: “Sizibophezele ekwakheni iSingapore ibe yindawo ekhethwayo yezidakamizwa zaseShayina ezintsha ukuze zithole imakethe yomhlaba wonke. Ngokusebenzisa inethiwekhi yezinsizakalo ze-Stellar Biotech ezisezingeni lendawo, izinkampani zemithi zaseShayina zingafinyelela imodeli yokwanda esebenza kahle ethi ‘Kubhaliswe eSingapore, Kuthengiswe kulo lonke iSoutheast Asia’, kunciphisa kakhulu umkhawulo wokuba namazinga omhlaba wonke.”

Ngokuba nezinzuzo ezinhlanu eziyinhloko, iSingapore isibe yindawo yamasu ekhethwayo yemithi yaseShayina eyiNoveli ukuba isetshenziswe eNingizimu-mpumalanga ye-Asia:

Ngokukhishwa kwe-iiMedia Ranking · 2025 China Innovative Drugs Global Expansion Leadership Ranking kanye nokusekelwa kochwepheshe kwe-Stellar Biotech, imithi yaseShayina enezinto ezintsha yenza ngokushesha ukungena emakethe enkulu yaseNingizimu-mpumalanga ye-Asia. Le modeli yokubambisana kwezindawo eziningi ayisethi nje iSingapore njengesikhungo sokudlulisela samaphilisi aseShayina, kodwa futhi kukhuthaza imvelo yezemithi ebonakala ngezinsiza eziningi zokwakha, izinsizakalo eziphelele zezimboni, nokufinyelela okubanzi emakethe. Njengoba izinkampani ezihamba phambili zemithi yaseShayina ezinezinto ezintsha zifika eSingapore nge-Stellar Biotech, iSingapore izoqhubeka nokudonsela izinsiza zochungechunge lwezimboni zemithi esifundeni, iqinise isikhundla sayo esibalulekile njengesikhungo sokwenza ucwaningo lwezokwelapha, ukusabalalisa, kanye nezokuthutha eNingizimu-mpumalanga ye-Asia, futhi ingeze umfutho oqhubekayo ekuthuthukisweni kwesikhathi eside kwesizwe.

Skena ukuze ulandele